Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGFα and epiregulin in androgen-independent prostate cancer cell lines

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 91-95

  Tørring, Niels ^a   Jørgensen, Per E ^b   Sørensen, Boe S ^a   Nexø, Ebba ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

Cell lines; ELISA; Epidermal growth factor; Epiregulin; Prostate cancer; RT PCR

Indexed keywords

AMPHIREGULIN; ANDROGEN; BETACELLULIN; EPIREGULIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANDROGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MULTIGENE FAMILY; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0034077278     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Dijkman GA and Debruyne FM: Epidemiology of prostate cancer. Eur Urol 30: 281-295, 1996.
2. Russell PJ, Bennett S and Stricker P: Growth factor involvement in progression of prostate cancer. Clin Chem 44: 705-723, 1998.
3. Sundaresan S, Roberts PE, King KL, Sliwkowski MX and Mather JP: Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology 139: 4756-4764, 1998.
4. Beerli RR and Hynes NE: Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Cell Biochem 271: 6071-6076, 1996.
5. Connolly JM and Rose DP: Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19: 173-180, 1991.
6. Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M and Dodd JG: Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 126: 151-158, 1993.
7. Freeman MR, Paul S, Kaefer M, Ishikawa M, Adam RM, Renshaw AA, Elenius K and Klagsbrun M: Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. J Cell Biochem 68: 328-338, 1998.
8. Sehgal I, Bailey J, Hitzemann K, Pittelkow MR and Maihle NJ: Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells. Mol Biol Cell 5: 339-347, 1994.
9. Daly JM, Olayioye MA, Wong AM, Neve R, Lane HA, Maurer FG and Hynes NE: NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of P13 kinase and p38 MAP kinase pathways. Oncogene 18: 3440-3451, 1999.
10. Jones JT, Akita RW and Sliwkowski MX: Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett 447: 227-231, 1999.
11. McKeehan WL, Adams PS and Rosser MP: Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 44: 1998-2010, 1984.
12. Levine AC, Ren M, Huber GK and Kirschenbaum A: The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 130: 2413-2419, 1992.
13. Tørring N, Sørensen BS, Boesch ST, Klocker H and Nexø E: Amphiregulin is expressed in primary cultures of prostate myofibroblasts, fibroblasts, epithelial cells, and in prostate tissue. Prostate Cancer and Prostatic Diseases 5: 262-267, 1998.
14. MacDonald A and Habib FK: Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 65: 177-182, 1992.
15. Fong CJ, Sherwood ER, Mendelsohn J, Lee C and Kozlowski JM: Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor alpha. Cancer Res 52: 5887-5892, 1992.
16. Harper ME, Goddard L, Glynne Jones E, Wilson DW, Price Thomas M, Peeling WB and Griffiths K: An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors. Prostate 23: 9-23, 1993.
17. Leav I, McNeal JE, Ziar J and Alroy J: The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions. Hum Pathol 29: 668-675, 1998.
18. Berthon P, Cussenot O, Hopwood L, Le Duc A, and Maitland NJ. Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: Differentiation pattern of non-tumorigenic cell lines. Int J One 6: 333-43, 1995.
19. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac P, Le Duc A and Calvo F: Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 146: 881-886, 1991.
20. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA and Murphy GP: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983.
21. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281, 1978.
22. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
23. Christensen ME, Engbæk F, Therkildsen MH, Bretlau P and Nexø E: A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 72: 1487-1493, 1995.
24. Jørgensen PE, Eskildsen L and Nexø E: Adsorption of EGF receptor ligands to test tubes - a factor with implications for studies on the potency of these peptides. Scand J Clin Lab Invest 59: 191-197, 1999.
25. Jørgensen PE, Vinter-Jensen L and Nexø E: An immunoassay designed to quantitate different molecular forms of rat urinary epidermal growth factor with equimolar potency: application on fresh rat urine. Scand J Clin Lab Invest 56: 25-36, 1996.
26. Bor MV, Sørensen BS, Rammer P and Nexø E: Calibrated user-friendly reverse transcriptase-PCR assay: quantitation of epidermal growth factor receptor mRNA. Clin Chem 44: 1154-1160, 1998.
27. Sørensen BS, Tørring N, Bor MV, and Nexø E: Quantitation of the mRNA expression of the EGF-system. Selective induction of HB-EGF and amphiregulin expression by growth factor stimulation of prostate stromal cells. (Submitted) 1999.
28. Davies P and Eaton CL: Binding of epidermal growth factor by human normal, hypertrophic, and carcinomatous prostate. Prostate 14: 123-132, 1989.
29. Myers RB, Kudlow JE and Grizzle WE: Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Mod Pathol 6: 733-737, 1993.
30. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C and Kozlowski JM: Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res 51: 2780-2785, 1991.
31. Connolly JM and Rose DP: Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16: 209-218, 1990.
32. Pinski J, Reile H, Halmos G, Groot K and Schally AV: Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Int J Cancer 59: 51-55, 1994.
33. Putz T, Culig Z, Eder IE, Nessler-Menardi G, Bartsch G, Grunicke H, Uberall F and Klocker H: Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res 59: 227-233, 1999.
34. Toyoda H, Komurasaki T, Uchida D, Takayama Y. Isobe T, Okuyama T and Hanada K: Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 270: 7495-7500, 1995.
35. Toyoda H, Komurasaki T, Uchida D and Morimoto S: Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 326: 69-75, 1997.